Open AccessPhase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
Author(s) -
Vitaly Margulis,
Mäneka Puligandla,
Edouard J. Trabulsi,
Elizabeth R. Plimack,
Elizabeth R. Kessler,
Surena F. Matin,
Guilherme Godoy,
Ajjai Alva,
Noah M. Hahn,
Michael A. Carducci,
Jean H. Hoffman-Censits,
Nirmish Singla,
Antony Ruggeri,
L. Howard,
John McCann,
Scott E. Delacroix,
Matthew Matthew,
Yagnesh Oza,
Jennifer Wang,
Benjamin A. Gartrell,
Maha Hussain,
Marc Matrana,
Sam Benjamin,
Guru Sonpavde,
Elaine T. Lam,
Brandon Bernard,
Yousef Zakharia,
S.E. Taylor,
Matthew I. Milowsky,
Sofia Ghani,
Somendra Pal Singh,
Kevin M. Kane,
Yull Arriaga,
Amee Morgans,
David D. Chism
Publication year - 2020
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000000644
Subject(s) - medicine , urothelial carcinoma , chemotherapy , carcinoma , oncology , urology , general surgery , surgery , cancer , bladder cancer
Data supporting neoadjuvant chemotherapy of high grade upper tract urothelial carcinoma are scant. In this multi-institution, prospective, phase II trial we investigated pathological complete responses after neoadjuvant chemotherapy of high grade upper tract urothelial carcinoma.